beginning in 1999, most recently as its executive vice president, chief financial officer and treasurer. Prior to joining the Company, he served as an executive with Brightpoint, Inc. Boor, age 50, joined the Company as senior vice president and chief financial officer in November 2011. Boor will also maintain his responsibilities as CFO. (NASDAQ: BLKB) announced that Anthony Boor, senior vice president and chief financial officer of Blackbaud, has been named interim president and chief executive officer until a permanent CEO is appointed. Prior to Celsion, Weaver served as CFO for six other biotechnology companies, including Poniard Pharmaceuticals, Talyst, Inc., Sirna Therapeutics, Nastech Pharmaceutical Co., Ilex Oncology and Prism Technologies and consulted for countless others.īlackbaud, Inc. where he served as chief financial officer after serving six years on Celsion’s board of directors. Weaver joins Fibrocell from oncology drug development company Celsion Corp. Weaver replaces Declan Daly, who will leave the company to reside full time in Ireland. (NYSE: FCSC) announced the appointment of Greg Weaver as Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary of the Company. Carlson joined Inteliquent in May 2004 and has served as Controller since that time.įibrocell Science, Inc. Eric Carlson, Inteliquent’s Controller, has been appointed to serve as interim principal financial officer and interim principal accounting officer. (NASDAQ: IQNT) announced that David Zwick, Chief Financial Officer and Executive Vice President, decided to step down to pursue other personal and career opportunities.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |